PXL/HO/Cir-049/2025-26                                                                                                     Date: 29.07.2025

Hyderabad

Subject: Request for Inputs on Issues Related to Saudi Food and Drug Authority (SFDA)

Dear Sir/Madam,,

We are pleased to inform you that a Virtual Meeting with the Saudi Food and Drug Authority (SFDA) is scheduled for 6th August 2025, to discuss key pharmaceutical issues concerning exports to Saudi Arabia.

In this context, Pharmexcil is compiling inputs from the pharmaceutical industry regarding any challenges or issues faced specifically with the SFDA. We request your esteemed organization to kindly share any concerns or observations encountered in relation to the following:

• Product registration or renewal with SFDA
• Regulatory or technical requirements
• Pricing-related issues 
• Inspection or audit-related concerns
• Import permissions or delays
• Communication or coordination with SFDA
• Any other matter impacting exports to Saudi Arabia

Your inputs will help us consolidate industry challenges and present them effectively at the appropriate forum for resolution.

We request you to submit your feedback by 2nd August 2025 to Mrs. Lakshmi Prasanna, Senior Director, Pharmexcil  (Email: regulatory@pharmexcil.com, CC: dgdesk@pharmexcil.com)

We look forward to your valuable cooperation.

Warm regards,

Raja Bhanu

Director General